The current valuation score of Organogenesis Holdings Inc is 8.96, ranking 66 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -22.08, which is -639.65% below the recent high of 119.16 and -3849.89% above the recent low of -872.19.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.